Home › Interdigitating Dendritic Cell Sarcoma
Interdigitating Dendritic Cell Sarcoma clinical trials recruiting in the U.S.
9 studies for Interdigitating Dendritic Cell Sarcoma are recruiting participants at sites across the United States.
Cities with the most studies
By state
Recently updated studies
CAR-T ceLL for Eradication of Active Residual Disease in LBCL (CLEAR-1 Study)
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT07443137Epcoritamab in Combination With Loncastuximab Tesirine in Relapsed/Refractory Large B-cell Lymphoma
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 15, 2026 · NCT06919939Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
Recruiting
Ages 18 and older · All sexes · Updated Oct 13, 2026 · NCT05940272Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
RecruitingPhase 1
1 Day – 21 Years · All sexes · Updated Aug 26, 2026 · NCT05857969This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 24, 2026 · NCT07121946SynKIR-310 for Relapsed/Refractory B-NHL
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Apr 14, 2026 · NCT06544265Zanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jan 23, 2026 · NCT06846463A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 18, 2025 · NCT06736613Q702 for the Treatment of Patients With Hematologic Malignancies
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 10, 2025 · NCT06712810From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.